Replimune (REPL) Amortizatization of Intangibles (2024 - 2026)
Replimune (REPL) reported Amortizatization of Intangibles of $607000.0 for Q1 2026, little changed on a YoY basis from $607000.0 in Q1 2025, and little changed sequentially from $607000.0 in Q4 2025.
Replimune (REPL) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Replimune (REPL) has 3 years of Amortizatization of Intangibles data on file, last reported at $607000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles changed 0.0% year-over-year to $607000.0; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (changed 0.0% YoY), and the FY2026 full-year result was $2.4 million, changed 0.0% from the prior year.
- Amortizatization of Intangibles steadied at $607000.0 in Q1 2026, from $607000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $607000.0 in Q2 2024 to a low of $607000.0 in Q2 2024.
- A 3-year average of $607000.0 and a median of $607000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Peak annual rise in Amortizatization of Intangibles reached 0.0% in 2025, while the deepest fall reached 0.0% in 2025.
- Tracing REPL's Amortizatization of Intangibles over 3 years: stood at $607000.0 in 2024, then changed by 0.0% to $607000.0 in 2025, then changed by 0.0% to $607000.0 in 2026.
- Business Quant data shows REPL's Amortizatization of Intangibles at $607000.0 in Q1 2026, $607000.0 in Q4 2025, and $607000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Replimune | 808.32 Mn | 808.32 Mn | - | 607,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 607,000.00 |
| Mar 31, 2026 | 607,000.00 |
| Dec 31, 2025 | 607,000.00 |
| Dec 31, 2025 | 607,000.00 |
| Sep 30, 2025 | 607,000.00 |
| Sep 30, 2025 | 607,000.00 |
| Jun 30, 2025 | 607,000.00 |
| Jun 30, 2025 | 607,000.00 |
| Mar 31, 2025 | 607,000.00 |
| Mar 31, 2025 | 607,000.00 |
| Dec 31, 2024 | 607,000.00 |
| Dec 31, 2024 | 607,000.00 |
| Sep 30, 2024 | 607,000.00 |
| Sep 30, 2024 | 607,000.00 |
| Jun 30, 2024 | 607,000.00 |
| Jun 30, 2024 | 607,000.00 |